PURPOSE: Molecular subtyping for pancreatic cancer has made substantial progress in recent years, facilitating the optimization of existing therapeutic approaches to improve clinical outcomes in pancreatic cancer. With advances in treatment combinations and choices, it is becoming increasingly impor...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!